Leerink Partnrs Has Negative Outlook of Danaher Q1 Earnings

Danaher Co. (NYSE:DHR) – Equities researchers at Leerink Partnrs lowered their Q1 2025 EPS estimates for Danaher in a research note issued to investors on Wednesday, December 11th. Leerink Partnrs analyst P. Souda now forecasts that the conglomerate will earn $2.02 per share for the quarter, down from their prior estimate of $2.06. The consensus estimate for Danaher’s current full-year earnings is $7.50 per share. Leerink Partnrs also issued estimates for Danaher’s Q2 2025 earnings at $1.88 EPS, Q3 2025 earnings at $1.86 EPS, Q4 2025 earnings at $2.46 EPS, FY2025 earnings at $8.22 EPS and FY2026 earnings at $9.22 EPS.

Several other research firms also recently commented on DHR. Barclays decreased their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. UBS Group lowered their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research report on Wednesday, October 23rd. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a report on Thursday, October 31st. Stifel Nicolaus upped their price target on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. Finally, Wells Fargo & Company initiated coverage on Danaher in a research note on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 price objective on the stock. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $287.95.

Danaher Trading Down 0.3 %

Shares of NYSE DHR opened at $233.53 on Monday. The stock has a market cap of $168.67 billion, a price-to-earnings ratio of 44.57, a PEG ratio of 4.33 and a beta of 0.83. The business has a 50 day simple moving average of $245.52 and a 200 day simple moving average of $257.13. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. Danaher has a 52 week low of $222.53 and a 52 week high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the previous year, the company posted $2.02 earnings per share. The business’s quarterly revenue was up 3.1% compared to the same quarter last year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. The ex-dividend date is Friday, December 27th. Danaher’s payout ratio is presently 20.61%.

Institutional Investors Weigh In On Danaher

A number of institutional investors have recently added to or reduced their stakes in DHR. Coronation Fund Managers Ltd. raised its stake in shares of Danaher by 29.9% in the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock valued at $1,596,000 after purchasing an additional 1,470 shares in the last quarter. MONECO Advisors LLC lifted its holdings in shares of Danaher by 12.1% during the 2nd quarter. MONECO Advisors LLC now owns 1,334 shares of the conglomerate’s stock worth $333,000 after acquiring an additional 144 shares during the period. Hall Laurie J Trustee raised its position in Danaher by 1.9% in the second quarter. Hall Laurie J Trustee now owns 20,464 shares of the conglomerate’s stock worth $5,113,000 after purchasing an additional 390 shares in the last quarter. CarsonAllaria Wealth Management Ltd. acquired a new position in Danaher in the second quarter worth about $25,000. Finally, Commerzbank Aktiengesellschaft FI boosted its holdings in Danaher by 5.2% during the second quarter. Commerzbank Aktiengesellschaft FI now owns 3,680 shares of the conglomerate’s stock valued at $920,000 after purchasing an additional 183 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.